Clinical Trial

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

Study acronym: IMMUNORATS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated February 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-01.
Trial Details
NCT Number NCT06626243
Lead Sponsor Scientific Institute San Raffaele
Collaborators: Memorial Sloan Kettering Cancer Center, Istituto Clinico Humanitas, Regina Elena Cancer Institute, Baptist Health South Florida, West Virginia University
Conditions Non-Small Cell Lung Cancer
Enrollment 140 participants
Start Date 2024-09-30
Primary Completion 2025-02-15 (estimated)
Study Completion 2025-10-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-29